Ceres Inc (CERE) Social Stream



Ceres Inc (CERE): $41.85

0.38 (+0.92%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

C

Add CERE to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#253 of 347

in industry

CEREVEL THERAPEUTICS HOLDINGS INC (CERE) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering CEREVEL THERAPEUTICS HOLDINGS INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-10-07 3 $39 $33 $36.333 $42.64 -14.79%
2021-11-10 3 $50 $37 $42 $42.64 -1.5%
2021-12-22 4 $50 $39 $47.25 $42.64 10.81%
2022-03-07 5 $50 $39 $47.8 $42.64 12.1%
2022-04-12 6 $50 $39 $47.8 $42.64 12.1%
2022-05-10 6 $50 $39 $47.5 $42.64 11.4%
2022-05-11 6 $50 $39 $45.666 $42.64 7.1%
2022-05-16 7 $50 $27 $43 $42.64 0.84%
2022-05-24 7 $50 $20 $42 $42.64 -1.5%
2022-08-02 8 $50 $20 $39.285 $42.64 -7.87%
2022-08-03 8 $50 $20 $40.125 $42.64 -5.9%
2022-08-09 8 $54 $20 $40.625 $42.64 -4.73%
2022-08-22 8 $54 $20 $42 $42.64 -1.5%
2022-08-23 8 $54 $20 $42.625 $42.64 -0.04%
2022-09-12 9 $52 $20 $42.375 $42.64 -0.62%
2022-09-21 9 $52 $28 $43.375 $42.64 1.72%
2022-09-26 10 $52 $28 $42.778 $42.64 0.32%
2022-09-29 11 $52 $28 $42.6 $42.64 -0.09%
2022-10-12 10 $52 $28 $42.6 $42.64 -0.09%
2022-10-20 11 $52 $28 $42.272 $42.64 -0.86%
2022-11-01 12 $52 $28 $42.083 $42.64 -1.31%
2022-11-09 12 $52 $28 $41.916 $42.64 -1.7%
2022-11-14 12 $52 $28 $41.583 $42.64 -2.48%
2022-12-19 13 $52 $28 $40.833 $42.64 -4.24%
2023-01-26 13 $52 $28 $41.25 $42.64 -3.26%
2023-02-24 13 $52 $28 $39.416 $42.64 -7.56%
2023-03-09 13 $52 $26 $39.083 $42.64 -8.34%
2023-03-17 13 $52 $26 $38.166 $42.64 -10.49%
2023-04-05 12 $52 $26 $37.454 $42.64 -12.16%
2023-05-03 13 $52 $26 $37.454 $42.64 -12.16%
2023-05-04 13 $46.001 $26 $36.818 $42.64 -13.65%
2023-05-08 13 $46.001 $28 $37.091 $42.64 -13.01%
2023-05-11 13 $46.001 $28 $37.272 $42.64 -12.59%
2023-06-06 13 $46.001 $29 $37.454 $42.64 -12.16%
2023-07-11 13 $46.001 $22 $36.818 $42.64 -13.65%
2023-08-02 13 $45 $22 $36.1 $42.64 -15.34%
2023-08-03 13 $44 $22 $34.9 $42.64 -18.15%
2023-08-07 12 $42 $24 $34.555 $42.64 -18.96%
2023-09-28 13 $42 $24 $34.4 $42.64 -19.32%
2023-11-02 12 $42 $24 $33.555 $42.64 -21.31%
2023-11-17 12 $42 $24 $34.2 $42.64 -19.79%
2023-11-20 13 $42 $24 $33.363 $42.64 -21.76%
2023-12-08 12 $45 $24 $36.09 $42.64 -15.36%
2023-12-15 12 $45 $24 $36.181 $42.64 -15.15%
2023-12-22 12 $45 $24 $36.636 $42.64 -14.08%

The Trend in the Analyst Price Target


Over the past 38 months, CERE's average price target has gone up $19.64.

Over the past 47 weeks, CERE's average upside potential has been 36.92%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-01-24 13 52.000 28 41.250 32.61 26.49%
2023-03-17 13 52.000 26 37.454 23.39 60.13%
2023-05-08 13 46.001 28 37.091 32.74 13.29%
2023-06-06 14 46.001 22 36.818 33.05 11.4%
2023-11-02 12 42.000 24 33.555 24.88 34.87%

CERE Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2.67 2 0 10 0 0 12

The Trend in the Broker Recommendations


CERE's average broker recommendation rating worsened by 1.5 over the prior 36 months.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • CERE has a higher upside potential (average analyst target price relative to current price) than 1139.8% of all US stocks.
  • CERE has a greater number of analysts covering the stock than 4014.97% of stocks in the mid market cap category.
  • To contextualize these metrics, consider that out of stocks in the mid market cap category, CEREVEL THERAPEUTICS HOLDINGS INC's variance in analysts' estimates is lower than -3453.03% of them.
  • CEREVEL THERAPEUTICS HOLDINGS INC's average analyst price target is greater than 3554.8% of Pharmaceutical Products stocks.

Stocks similar to CEREVEL THERAPEUTICS HOLDINGS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are NUVB, NKTX, and ALXO.

Is CERE a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!